Drug susceptibility testing of anaerobic protozoa
- PMID: 11353630
- PMCID: PMC90550
- DOI: 10.1128/AAC.45.6.1810-1814.2001
Drug susceptibility testing of anaerobic protozoa
Abstract
A simple technique for routine, reproducible global surveillance of the drug susceptibility status of the anaerobic protozoa Trichomonas, Entamoeba, and Giardia is described. Data collected using this technique can be readily compared among different laboratories and with previously reported data. The technique employs a commercially available sachet and bag system to generate a low-oxygen environment and log(2) drug dilutions in microtiter plates, which can be monitored without aerobic exposure, to assay drug-resistant laboratory lines and clinically resistant isolates. MICs (after 2 days) of 3.2 and 25 microM indicated metronidazole-sensitive and highly clinically resistant isolates of T. vaginalis in anaerobic assays, respectively. The aerobic MICs were 25 and >200 microM. MICs (1 day) of 12.5 to 25 microM were found for axenic lines of E. histolytica, and MICs for G. duodenalis (3 days) ranged from 6.3 microM for metronidazole-sensitive isolates to 50 microM for laboratory metronidazole-resistant lines. This technique should encourage more extensive monitoring of drug resistance in these organisms.
Similar articles
-
Drug targets and mechanisms of resistance in the anaerobic protozoa.Clin Microbiol Rev. 2001 Jan;14(1):150-64. doi: 10.1128/CMR.14.1.150-164.2001. Clin Microbiol Rev. 2001. PMID: 11148007 Free PMC article. Review.
-
Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):321-327. doi: 10.1016/j.ijpddr.2017.09.001. Epub 2017 Sep 5. Int J Parasitol Drugs Drug Resist. 2017. PMID: 28910741 Free PMC article.
-
In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.J Eukaryot Microbiol. 2002 May-Jun;49(3):201-8. doi: 10.1111/j.1550-7408.2002.tb00523.x. J Eukaryot Microbiol. 2002. PMID: 12120985
-
In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.J Antimicrob Chemother. 2002 Jan;49(1):103-11. doi: 10.1093/jac/49.1.103. J Antimicrob Chemother. 2002. PMID: 11751773
-
Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook.Parasitol Res. 2001 Sep;87(9):785-6. doi: 10.1007/s004360100405. Parasitol Res. 2001. PMID: 11570567 Review.
Cited by
-
Development of metronidazole-resistant lines of Blastocystis sp.Parasitol Res. 2012 Jul;111(1):441-50. doi: 10.1007/s00436-012-2860-7. Epub 2012 Feb 24. Parasitol Res. 2012. PMID: 22362365
-
In Vitro Susceptibility of Iranian Isolates of Trichomonas vaginalis to Metronidazole.Iran J Parasitol. 2016 Jan-Mar;11(1):46-51. Iran J Parasitol. 2016. PMID: 27095968 Free PMC article.
-
Comparative membrane proteomic analysis of Tritrichomonas foetus isolates.Sci Rep. 2024 Jul 24;14(1):17033. doi: 10.1038/s41598-024-67827-8. Sci Rep. 2024. PMID: 39043862 Free PMC article.
-
In Vitro Effect of 5-Nitroimidazole Drugs against Trichomonas vaginalis Clinical Isolates.Microbiol Spectr. 2022 Aug 31;10(4):e0091222. doi: 10.1128/spectrum.00912-22. Epub 2022 Jul 13. Microbiol Spectr. 2022. PMID: 35863010 Free PMC article.
-
Detection of metronidazole resistance in Trichomonas vaginalis using uncultured vaginal swabs.Parasitol Res. 2022 Aug;121(8):2421-2432. doi: 10.1007/s00436-022-07548-x. Epub 2022 Jun 3. Parasitol Res. 2022. PMID: 35657426
References
-
- Boreham P F L. Giardiasis and its control. Pharm J. 1991;234:271–274.
-
- Boreham P F L, Phillips R E, Shepherd R W. The sensitivity of Giardia intestinalis to drugs in vitro. J Antimicrob Chemother. 1984;14:449–461. - PubMed
-
- Boreham P F L, Phillips R E, Shepherd R W. Altered uptake of metronidazole in vitro by stocks of Giardai intestinalis with different drug sensitivities. Trans R Soc Trop Med Hyg. 1988;82:104–106. - PubMed
-
- Bowden F J, Garnett G P. Why is Trichomonas vaginalis ignored? Sex Transm Infect. 1999;75:372–373. - PubMed
-
- Brown D M, Upcroft J A, Dodd H N, Chen N, Upcroft P. Alternative 2-keto acid oxidoreductase activities in Trichomonas vaginalis. Mol Biochem Parasitol. 1999;98:203–214. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources